Newsletter | January 28, 2020

01.28.20 -- Melting Reveals Drug Targets In A Living Organism

 
Industry Insights
Pharmacokinetic Strategies In CNS Drug Discovery
White Paper | GVK Biosciences

The failure rate for new drugs targeting CNS diseases is high, both preclinically and clinically. This paper discusses successful PK approaches to help CNS targeted drug discovery and development efforts.

Optimizing Drug Safety And Efficacy Of Complex Next-Generation Biologics
White Paper | GE Healthcare Life Sciences

Learn what challenges exist when developing biologic drugs to be efficacious but safe and how novel analytical techniques, like surface plasmon resonance, can help circumvent these issues and optimize development.

Choosing The Right CDMO For Late Phase Clinical Trials
Webinar | Thermo Fisher Scientific

For many pharmaceutical companies that do not have their own facilities, choosing the right partner for late-phase clinical trials and commercial production is a critical aspect in the management of parenteral products. This webinar offers insight into the importance of looking for a partner with extensive experience in the parenteral arena, as products move through clinical phases and toward commercialization.

Most Popular News
Solutions
Nuvia aPrime 4A Hydrophobic AEX Resin
Bio-Rad Laboratories, Inc.
Life Science Leader Magazine
 

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.